Equity Investment
Oriza Greenwillow is an investment platform of Oriza Holdings focusing on the Southeast Asian market. The investment fields will focus on consumer goods, technology-based enterprises, medical and health care and other fields, mainly in the early and growth stages.
Oriza Greenwillow is a joint venture between Oriza Holdings and Singapore Greenwillow Capital, which will help Oriza Holdings continue to expand its overseas layout and further its internationalization. Oriza Greenwillow will use its accumulated industrial investment experience over the years to invest in leading technology companies in Singapore and other countries, fully tap the potential opportunities in the Southeast Asian market, and continue to create value for both parties.
Partner
-
Weiqiang Lu
Managing Partner
MBA, Sloan School of Business, Massachusetts Institute of Technology, United States of America; First Class Honours degree in Mathematics, University of Oxford, United Kingdom.
Previously Managing Director, Corporate Strategy and Head of Real Estate Investments, Asia Pacific, Government of Singapore Investment Corporation (GIC); Chief Executive Officer, South East Asia, Executive Vice President, Development and Investments, Ascendas; Senior Vice President, Investments and Asset Management, Capita Land and Head of CapitaMalls India; Deputy Permanent Secretary, Ministry of Trade and Industry, Singapore; Brigadier General of the Army, Ministry of Defence, Singapore; Commander-in-Chief, 3rd Division, Singapore Army; Assistant Chief of the Army Staff (Operations). -
Junqiang Chen
Managing Partner
Honors degree from Ohio University's College of Business.
Previously, he was a member of the Investment Committee of Xiangfeng Capital, managing its investment portfolio in China and Southeast Asia; Vice President of Whispir, an Australian-listed software company; in charge of the strategic relations, business development, and marketing divisions of Singapore Technologies (ST); serial entrepreneur, angel investor, and founder of a number of tech startups in China and Singapore; and economic officer in the Ministry of Trade and Industry of Singapore. -
Wenyao Huang
Managing Partner
Bachelor of Clinical Medicine, National University of Singapore.
Previously Founder and CEO of Asia Genomics; Managing Director of Imagene Labs; VP of International Business at Parkway Health; Partner at Formation8 Partners, a venture capital fund; Head of Silicon Valley for Singapore's Economic Development Board Investment (EDB Investment); Angel Investor; 7 years of clinical experience.